| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/10/2011 | EP2353609A1 Immunization compositions and methods |
| 08/10/2011 | EP2353608A1 Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
| 08/10/2011 | EP2353012A1 Biomarkers and methods for detecting and treating spinal and joint pain |
| 08/10/2011 | EP2353009A2 Use of isolated polypeptides having antigenic properties against mycoplasma pneumoniae, and of corresponding polynucleotides and antibodies |
| 08/10/2011 | EP2352761A2 Inhibition of plgf to treat philadelphia chromosome positive leukemia |
| 08/10/2011 | EP2352524A1 Tcl1 AS A TRANSCRIPTIONAL REGULATOR |
| 08/10/2011 | EP2352523A1 Improved anti-cd19 antibodies |
| 08/10/2011 | EP2352521A1 Immunoglobulin variants and uses thereof |
| 08/10/2011 | EP2352520A1 Vaccination with poxvirus vectors via mechanical epidermal disruption |
| 08/10/2011 | EP2352519A1 Composition comprising sortase anchored surface proteins of streptococcus uberis |
| 08/10/2011 | EP2352518A1 Vaccine strains of brachyspira hyodysenteriae |
| 08/10/2011 | EP2352517A1 Methods and compositions for treating complement-associated disorders |
| 08/10/2011 | EP2352516A2 Immunization of avians by mucosal administration of non-replicating vectored vaccines |
| 08/10/2011 | EP2352504A2 Treatment of proliferative disorders with a death receptor agonist |
| 08/10/2011 | EP1963484B1 Method of producing rough strains of bacteria and uses thereof |
| 08/10/2011 | EP1709073B1 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb) |
| 08/10/2011 | EP1565581B1 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 08/10/2011 | EP1461079B1 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 08/10/2011 | EP1438388B1 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/10/2011 | EP1212349B1 Recombinant subunit vaccine |
| 08/10/2011 | EP1190074B1 Recombinant anti-cd40 antibody and uses thereof |
| 08/10/2011 | EP1068296B1 Compositions for eliciting an immune response to a telomerase antigen |
| 08/10/2011 | CN1904053B Fusion gene of Japan schistosome antigen gene and constituted DNA vaccin and preparing process |
| 08/10/2011 | CN1817906B Antibody against human parathormone related peptides |
| 08/10/2011 | CN1796546B Optimal placement of a robust solvent/detergent process post viral ultrafiltration of an immune gamma globulin |
| 08/10/2011 | CN102149825A Prostaglandin E2 dual variable domain immunoglobulins and uses thereof |
| 08/10/2011 | CN102149730A FGF-R4 receptor-specific antagonists |
| 08/10/2011 | CN102149728A Methods for inhibiting ocular angiogenesis |
| 08/10/2011 | CN102149406A Compositions and methods for the treatment of hepatitis c |
| 08/10/2011 | CN102149405A Influenza hemagglutinin and neuraminidase variants |
| 08/10/2011 | CN102149404A Vaccines comprising TB 10.4 |
| 08/10/2011 | CN102146137A Antibody to beta-amyloid peptide and application thereof |
| 08/10/2011 | CN102145179A Application of IL-1ra-Fcepsilon fusion gene and coded protein thereof to treatment on allergic rhinitis |
| 08/10/2011 | CN102145170A Sensitizer for radiotherapy and chemotherapy of malignant tumor |
| 08/10/2011 | CN102145167A Recombinant human metapneumovirus vaccine |
| 08/10/2011 | CN102145166A Infectious bursal disease VP2 subunit vaccine of recombinant avian influenza M2e, construction method of vaccine and use of vaccine |
| 08/10/2011 | CN102145165A Porcine circovirus type 2 and use thereof |
| 08/10/2011 | CN102144977A Preparation method of growth hormone nanoparticles with biological activity |
| 08/10/2011 | CN101514230B Monoclone antibody of ARD1 and application thereof |
| 08/10/2011 | CN101503472B Human source neutralizing antibody specific against botulinum neurotoxin type A and use thereof |
| 08/10/2011 | CN101475644B Novel targeted fusion protein with anti-inflammatory action and use thereof |
| 08/10/2011 | CN101407782B Oral DNA vaccine for promoting growth of animal by non-antibiotics resistance gene screening, and preparation and use thereof |
| 08/10/2011 | CN101394868B Strong immune induction by using combination of adenovirus type-5/type-35 vector and vaccinia virus mva vector |
| 08/10/2011 | CN101333255B BP180 single chain antibody of humanized anti-bullous pemphigoid antigen and its use |
| 08/10/2011 | CN101084015B Antibody formulation in histidine-acetate buffer |
| 08/09/2011 | US7994388 Depletion of endogenous primordial germ cells in avian species |
| 08/09/2011 | US7994290 Effector function enhanced recombinant antibody composition |
| 08/09/2011 | US7994289 Humanized anti-CD3 antibodies |
| 08/09/2011 | US7994288 Allergenic proteins of natural rubber latex, their production and use in assays |
| 08/09/2011 | US7994287 Antibodies which bind human CXCR3 |
| 08/09/2011 | US7994283 Dimeric proteins for immunization |
| 08/09/2011 | US7994282 Card proteins involved in cell death regulation |
| 08/09/2011 | US7994279 Altered peptide ligands of GAD65 |
| 08/09/2011 | US7994193 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 08/09/2011 | US7994146 Method of enhancing an immune response |
| 08/09/2011 | US7994135 Antibodies conjugated to Auristatin analogs via a maleimidocaproyl lingages; for treating cancer, autoimmune diseases and infectious diseases |
| 08/09/2011 | US7994128 Conotoxin peptides useful as inhibitors of neuronal amine transporters |
| 08/09/2011 | US7994124 Using granulocyte-macrophage colony stimulating factor (GM-CSF) cysteine mutein as therapeutic in treatment of neutropenia |
| 08/09/2011 | US7994116 Methods for reduction of adhesion formation using cytokine inhibitors |
| 08/09/2011 | US7993924 Using myxoviral vector as somatic gene therapeutic tool; genetic vaccines |
| 08/09/2011 | US7993878 Antibodies to human IL-1β |
| 08/09/2011 | US7993867 Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen |
| 08/09/2011 | US7993866 Diagnosis, prevention and treatment of crohn's disease using the OmpC antigen |
| 08/09/2011 | US7993865 Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
| 08/09/2011 | US7993849 Human TIMP-1 antibodies |
| 08/09/2011 | US7993834 Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapy |
| 08/09/2011 | US7993829 HPRP4s modifiers of the p53 pathway and methods of use |
| 08/09/2011 | US7993659 TLR9 agonist and CD40 agonist immunostimulatory combinations |
| 08/09/2011 | US7993658 Targeting of triacylclycerol synthase gene for tuberculosis treatment |
| 08/09/2011 | US7993657 Antibody profiles characteristic of tuberculosis state |
| 08/09/2011 | US7993655 Vaccine for avian influenza and methods of use |
| 08/09/2011 | US7993652 Immunoprotective influenza antigen and its use in vaccination |
| 08/09/2011 | US7993651 Administering gag protein; vaccines for human immunodeficiency virus |
| 08/09/2011 | US7993650 Polypeptides having binding affinity for HER2 |
| 08/09/2011 | US7993648 Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody |
| 08/09/2011 | US7993647 Monoclonal antibodies to HIV-1 and methods of using same |
| 08/09/2011 | US7993646 Hexokinase specific immunoglobulin for use in treatment and prevention of asthma, chronic obstructive pulmonary disease, multiple sclerosis, psoriasis, rheumatoid arthritis, osteoarthritis, inflammatory bowel, immune mediated diabetes and pancreatic disorders |
| 08/09/2011 | US7993645 Human anti-IL-23 antibodies, compositions, methods and uses |
| 08/09/2011 | US7993644 Tissue factor antibodies and uses thereof |
| 08/09/2011 | US7993643 Using low density lipoprotein receptor specific immunoglobulin for treatment and prevention of athersclerotic, kidney and inflammatory disorders |
| 08/09/2011 | US7993642 Anti-MPL antibodies |
| 08/09/2011 | US7993641 Methods of treatment using anti-CD3 antibodies |
| 08/09/2011 | US7993640 Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody |
| 08/09/2011 | CA2474645C Compositions and methods for systemic inhibition of cartilage degradation |
| 08/09/2011 | CA2450179C Identification of stat6 modulators using ncoa-1/stat6 interaction |
| 08/09/2011 | CA2447921C Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules |
| 08/09/2011 | CA2438092C Ttk in diagnosis and as a therapeutic target in cancer |
| 08/09/2011 | CA2409209C Chimeric arterivirus-like particles |
| 08/09/2011 | CA2370278C Chimeric lyssavirus nucleic acids and polypeptides |
| 08/09/2011 | CA2367360C Insulin-like growth factor binding protein-4 protease |
| 08/09/2011 | CA2366462C Two-step immunization procedure against chlamydia infection |
| 08/09/2011 | CA2350340C B-cell epitopes of hsp65 and uses thereof |
| 08/09/2011 | CA2332115C Aav structural protein, its preparation and use |
| 08/09/2011 | CA2302809C Membrane virus host range mutations and their uses as vaccine substrates |
| 08/09/2011 | CA2253240C Hereditary hemochromatosis gene |
| 08/09/2011 | CA2243559C Pharmaceutical composition for immunomodulation |
| 08/09/2011 | CA2146328C C-c ckr-1, c-c chemokine receptor |
| 08/04/2011 | WO2011094716A1 Use of tyrosine kinase inhibitors for treatment of prolactinoma |
| 08/04/2011 | WO2011094538A1 Depletion of teratoma-forming pluripotent stem cells |
| 08/04/2011 | WO2011094465A1 Methods of treating autoimmune diseases with dll4 antagonists |